Shared care management of patients with type 2 diabetes across the primary and secondary healthcare sectors: study protocol for a randomised controlled trial.

Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE

Original Publication: [London] : BioMed Central, 2006-

Clinical Protocols* ; Health Care Sector* ; Patient Care Management*; Diabetes Mellitus, Type 2/*therapy; Cross-Sectional Studies ; Humans ; Outcome Assessment, Health Care ; Quality of Life

Background: The prevalence of type 2 diabetes (T2D) is growing globally and hospital-based outpatient clinics are burdened with increasing numbers of patients. To ensure high quality treatment and care, it is necessary to structurally reorganise the management of patients with T2D. The objective of this study is to test if T2D patients (who are at intermediate risk of or are already having incipient diabetic complications) jointly managed by a hospital-based outpatient clinic and general practitioners (shared care programme) have a non-inferior outcome compared to an established programme in a specialised (hospital based) outpatient diabetes clinic.
Methods: The study is designed as a randomised controlled trial. The shared care model will be tested during a period of 3 years, with data collection at baseline and at 12, 24 and 36 months. All patients will be offered four medical visits a year; the shared care intervention consists of one annual comprehensive check-up at the outpatient clinic and three quarterly visits at the general practitioners' office. The control group will be followed with four quarterly visits at the outpatient clinic, including an annual comprehensive check-up. In the outpatient clinic, the patients will be treated by a specialised diabetes team, including an endocrinologist. On the basis of a predefined stratification model, we will recruit patients stratified to be at intermediate risk of or already having incipient diabetic complications. We plan to include 140 patients. The primary outcome is glycated haemoglobin. Other outcome measures include (1) the proportion of patients who meet the Danish standard indicators reflecting quality of care; (2) quality of life measured by Short Form 36; and (3) the functionality of the patients' families measured by Family Assessment Measure III. The experiences of the patients and families when participating in the shared care program will be explored by collecting dyadic interviews.
Discussion: This study will evaluate the quality of a shared care programme for patients with T2D, and provide evidence about advantages and disadvantages compared with a programme in a specialised outpatient clinic. The results may provide important information on how to organise the care for patients with T2D in the future.
Trial Registration: This trial was registered with Clinicaltrials.gov on 21 October 2015, registration number: NCT02586545 .

Diabet Med. 1993 Jan-Feb;10(1):81-6. (PMID: 8435994)
Diabetes Res Clin Pract. 2014 Feb;103(2):137-49. (PMID: 24630390)
Diabetologia. 2002 Jul;45(7):S13-7. (PMID: 12136406)
Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004910. (PMID: 17636778)
Diabet Med. 1994 Apr;11(3):253-61. (PMID: 8033523)
Diabetes Care. 2012 Jun;35(6):1252-7. (PMID: 22619288)
Health Soc Care Community. 2012 Nov;20(6):591-8. (PMID: 22758654)
Diabetes Care. 2015 Jan;38 Suppl:S33-40. (PMID: 25537705)
BMJ Open. 2012 Aug 29;2(4):. (PMID: 22936821)
Diabetologia. 2013 Dec;56(12):2601-8. (PMID: 24114114)
Eur J Prev Cardiol. 2013 Dec;20(6):1095-105. (PMID: 22605788)
Diabet Med. 2005 Oct;22(10):1379-85. (PMID: 16176200)
PLoS Med. 2006 Nov;3(11):e442. (PMID: 17132052)
Addiction. 1993 Jun;88(6):791-804. (PMID: 8329970)
J Clin Epidemiol. 1998 Nov;51(11):1001-11. (PMID: 9817118)
Fam Pract. 2004 Feb;21(1):39-45. (PMID: 14760042)
Korean J Pediatr. 2012 Nov;55(11):403-7. (PMID: 23227058)
Med Care. 1994 Jan;32(1):40-66. (PMID: 8277801)
BMJ. 2006 Feb 18;332(7538):413-6. (PMID: 16484270)
Qual Health Res. 2013 Sep;23(9):1276-84. (PMID: 23925406)
Diabetes Care. 2015 Jan;38 Suppl:S49-57. (PMID: 25537708)
BMC Health Serv Res. 2009 Oct 07;9:179. (PMID: 19811624)
Stroke. 2015 May;46(5):e121-2. (PMID: 25873596)
J Clin Endocrinol Metab. 2014 Apr;99(4):E642-6. (PMID: 24483155)
Diabetes Care. 2015 Jan;38 Suppl:S58-66. (PMID: 25537710)
Med Care. 1992 Jun;30(6):473-83. (PMID: 1593914)
Cochrane Database Syst Rev. 2001;(1):CD001481. (PMID: 11279717)
BMC Health Serv Res. 2016 Apr 09;16:124. (PMID: 27061722)
Diabetologia. 2015 Mar;58(3):429-42. (PMID: 25583541)
JAMA. 2012 Dec 26;308(24):2594-604. (PMID: 23268518)
Indian J Endocrinol Metab. 2013 Oct;17(Suppl 1):S95-9. (PMID: 24251231)
Value Health. 2009 Nov-Dec;12(8):1168-75. (PMID: 19558371)
N Engl J Med. 2008 Feb 7;358(6):580-91. (PMID: 18256393)
N Engl J Med. 2008 Oct 9;359(15):1577-89. (PMID: 18784090)
Int J Clin Pract. 2012 May;66(5):457-64. (PMID: 22452524)
BMJ. 1998 Sep 12;317(7160):703-13. (PMID: 9732337)
Diabet Med. 2013 Sep;30(9):1112-21. (PMID: 23758279)
Diabet Med. 2015 Apr;32(4):459-66. (PMID: 25439048)

Keywords: Diabetes care; Diabetes complications; Randomised controlled trial; Risk stratification; Shared care; Type 2 diabetes

ClinicalTrials.gov NCT02586545

Date Created: 20160605 Date Completed: 20171205 Latest Revision: 20240325

20240325

PMC4893266

10.1186/s13063-016-1409-y

27259669